Skip to Content

Tiagabine Pregnancy and Breastfeeding Warnings

Tiagabine is also known as: Gabitril

Tiagabine Pregnancy Warnings

To provide information regarding the effects of in utero exposure to tiagabine, physicians are advised to recommend that pregnant patients taking tiagabine enroll in the North American Antiepileptic Drug (NAAED) Pregnancy Registry. This can be done by calling the toll free number 1-888-233-2334, and must be done by patients themselves. Information on the registry can also be found at the website

Tiagabine has been assigned to pregnancy category C. High dose reproductive studies conducted with rats and rabbits have demonstrated teratogenic effects (craniofacial, appendicular, and visceral malformations), maternal toxicity (transient weight loss or reduced maternal weight gain during gestation), as well as adverse fetal outcome when the drug is administered during late gestation and throughout parturition (increase in stillbirths and decrease in postnatal offspring viability). No adverse fetal or maternal effects were observed with doses equivalent to three times the maximum recommended human dose on a mg/m2 basis. There are no controlled data in human pregnancy. Tiagabine should only be given during pregnancy when need has been clearly established.

See references

Tiagabine Breastfeeding Warnings

Tiagabine and its metabolites have been shown to pass into the milk of lactating rats.

There are no data on the excretion of tiagabine or its metabolites into human milk. The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Gabitril (tiagabine)." Abbott Pharmaceutical, Abbott Park, IL.

References for breastfeeding information

  1. "Product Information. Gabitril (tiagabine)." Abbott Pharmaceutical, Abbott Park, IL.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.